254 related articles for article (PubMed ID: 27350079)
1. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion.
Lee JH; Park SY; Shin YW; Hong KW; Kim CD; Sung SM; Kim KY; Lee WS
Brain Res; 2006 Apr; 1082(1):182-91. PubMed ID: 16516167
[TBL] [Abstract][Full Text] [Related]
3. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
[TBL] [Abstract][Full Text] [Related]
4. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
[TBL] [Abstract][Full Text] [Related]
5. Epimedium flavonoids improve cognitive impairment and white matter lesions induced by chronic cerebral hypoperfusion through inhibiting the Lingo-1/Fyn/ROCK pathway and activating the BDNF/NRG1/PI3K pathway in rats.
Niu HM; Wang MY; Ma DL; Chen XP; Zhang L; Li YL; Zhang L; Li L
Brain Res; 2020 Sep; 1743():146902. PubMed ID: 32446949
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol alleviates white matter degeneration caused by chronic cerebral hypoperfusion in mice: Implication of its mechanism from gene expression analysis.
Ohtomo R; Bannai T; Ohtomo G; Shindo A; Tomimoto H; Tsuji S; Iwata A
Neurosci Lett; 2018 Jan; 662():247-252. PubMed ID: 29080698
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood-brain barrier impairment.
Manukjan N; Majcher D; Leenders P; Caiment F; van Herwijnen M; Smeets HJ; Suidgeest E; van der Weerd L; Vanmierlo T; Jansen JFA; Backes WH; van Oostenbrugge RJ; Staals J; Fulton D; Ahmed Z; Blankesteijn WM; Foulquier S
Acta Neuropathol Commun; 2023 Aug; 11(1):128. PubMed ID: 37550790
[TBL] [Abstract][Full Text] [Related]
8. Reduction in pericyte coverage leads to blood-brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion.
Sun Z; Gao C; Gao D; Sun R; Li W; Wang F; Wang Y; Cao H; Zhou G; Zhang J; Shang J
Fluids Barriers CNS; 2021 May; 18(1):21. PubMed ID: 33952281
[TBL] [Abstract][Full Text] [Related]
9. Interaction between hypertension and cerebral hypoperfusion in the development of cognitive dysfunction and white matter pathology in rats.
Choi JY; Cui Y; Kim BG
Neuroscience; 2015 Sep; 303():115-25. PubMed ID: 26143013
[TBL] [Abstract][Full Text] [Related]
10. Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion.
Kitamura A; Manso Y; Duncombe J; Searcy J; Koudelka J; Binnie M; Webster S; Lennen R; Jansen M; Marshall I; Ihara M; Kalaria RN; Horsburgh K
Sci Rep; 2017 Jun; 7(1):4299. PubMed ID: 28655874
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion.
Watanabe T; Zhang N; Liu M; Tanaka R; Mizuno Y; Urabe T
Stroke; 2006 Jun; 37(6):1539-45. PubMed ID: 16645134
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol strengthens barrier integrity in brain endothelial cells.
Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M
Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787
[TBL] [Abstract][Full Text] [Related]
13. Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats.
Lee JH; Park SY; Shin YW; Kim CD; Lee WS; Hong KW
Brain Res; 2007 Dec; 1185():246-55. PubMed ID: 17936728
[TBL] [Abstract][Full Text] [Related]
14. Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.
Choi BR; Kim DH; Back DB; Kang CH; Moon WJ; Han JS; Choi DH; Kwon KJ; Shin CY; Kim BR; Lee J; Han SH; Kim HY
Stroke; 2016 Feb; 47(2):542-7. PubMed ID: 26670084
[TBL] [Abstract][Full Text] [Related]
15. Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion.
Khoshnam SE; Farbood Y; Fathi Moghaddam H; Sarkaki A; Badavi M; Khorsandi L
Metab Brain Dis; 2018 Jun; 33(3):785-793. PubMed ID: 29356980
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
17. The ameliorative effects of exercise on cognitive impairment and white matter injury from blood-brain barrier disruption induced by chronic cerebral hypoperfusion in adolescent rats.
Lee JM; Park JM; Song MK; Oh YJ; Kim CJ; Kim YJ
Neurosci Lett; 2017 Jan; 638():83-89. PubMed ID: 27956237
[TBL] [Abstract][Full Text] [Related]
18. Microparticles generated during chronic cerebral ischemia increase the permeability of microvascular endothelial barriers in vitro.
Edrissi H; Schock SC; Hakim AM; Thompson CS
Brain Res; 2016 Mar; 1634():83-93. PubMed ID: 26723565
[TBL] [Abstract][Full Text] [Related]
19. Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling.
Lee KM; Bang J; Kim BY; Lee IS; Han JS; Hwang BY; Jeon WK
BMC Complement Altern Med; 2015 Apr; 15():125. PubMed ID: 25898017
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.
Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H
J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
